Signaling via the insulin-like growth factor-I receptor: Does it differ from insulin receptor signaling?

Cytokine and Growth Factor Reviews

Volumn 7, Issue 2, 1996, Pages 153-159

  Blakesley, Vicky A ^b   Scrimgeour, Angus ^b   Esposito, Diana ^b   Le Roith, Derek ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NONE

Author keywords

IGF 1 receptor; Insulin receptor; Signaling

Indexed keywords

INSULIN RECEPTOR; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

BINDING AFFINITY; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG RECEPTOR BINDING; ENDOCYTOSIS; ENZYME SPECIFICITY; ENZYME SUBSTRATE; GENE TARGETING; HUMAN; HUMAN CELL; INSULIN RESISTANCE; LIGAND BINDING; METABOLIC REGULATION; METABOLISM; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 0030207118     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/1359-6101(96)00015-9     Document Type: Short Survey

References (52)

1. 1. Kahn CR. Insulin action diabetogenes, and the cause of type II diabetes. Diabetes 1994, 43, 1066-1984.
2. 2. Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocr Rev 1989, 10, 68-91.
3. 3. Jones JJ, Clemmons DR. Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 1995, 16, 3-18.
4. 4. LeRoith D, Werner H, Beitner-Johnson D, Roberts Jr CT. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 1995, 16, 143-163.
5. 5. Yarden Y, Ullrich A. Growth factor receptor tyrosine kinases. Ann Rev Biochem 1988, 57, 443-478.
6. 6. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990, 61, 203-212.
7. 7. Moses AC. Is insulin a growth factor? In LeRoith D, ed. Insulin-like Growth Factors: Molecular and Cellular Aspects. Boca Raton FL, CRC, 1991, pp. 245-270.
8. 8. De Meyts P, Wallach B, Christoffersen CT et al. The insulin-like growth factor-I receptor. Structure, ligand binding mechanism and signal transduction. Horm Res 1994, 42, 152-169.
9. 9. Pillemer G, Lugasi-Evgi H, Scharovski G et al. Insulin dependence of murine lymphoid T-cell leukemia. Int J Cancer 1992, 50, 80-85.
10. 10. Myers MG, White MF. New frontiers in insulin receptor substrate signaling. Trends Endocr Metab 1995, 6, 209-215.
11. 11. Myers MG, Grammer TC, Wang LM et al. IRS-1 mediates PI-3′ kinase and p70S6k signaling during insulin, IGF-I and IL-4 stimulation. J Biol Chem 1994, 269, 28783-28789.
12. 12. Gold G. Insulin structure and biosynthesis. In Draznin B, Melmed S, LeRoith D, eds. Insulin Secretion. New York, Alan R Liss Inc., 1989, pp. 25-35.
13. 13. Sussenbach JS, Steenbergh PH, Holthuizen P. Structure and expression of the human insulin-like growth factor genes. Growth Regul 1992, 2, 1-9.
14. 14. Ullrich A. Bell JR, Chen EY et al. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 1985, 313, 756-759.
15. 15. Ebina Y, Ellis L, Jarnagin K et al. The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signalling. Cell 1985, 40, 747-758.
16. 16. Ullrich A, Gray A, Tam AW et al. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 1986, 5, 2503-2512.
17. 17. Abbott AM, Beuno R, Pedrini MT et al. Insulin-like growth factor I receptor gene structure. J Biol Chem 1992, 267, 10759-10763.
18. 18. Czech M. Structural and functional homologies in the receptors for insulin and the insulin-like growth factors. Cell 1982, 31, 8-10.
19. 19. Andersen AS, Kjedsen T, Wiberg FC et al. Identification of determinants that confer ligand specificity on the insulin receptor. J Biol Chem 1992, 267, 13681-13686.
20. 20. Kjedsen T, Andersen AS, Wibert FC et al. The ligand specificities of the insulin receptor and the insulin-like growth factor-I receptor reside in different regions of a common binding site. Proc Natl Acad Sci USA 1991, 88, 4404-4408.
21. 21. Schumacher R, Mosthaf L, Schlessinger J et al. Insulin and insulin-like growth factor-I binding specificity is determined by distinct regions of their cognate receptors. J Biol Chem 1991, 266, 19288-19295.
22. 22. De Meyts P, Gu J-L, Shymko RM et al. Identification of a ligand-binding region of the human insulin receptor encoded by the second exon of the gene. Molec Endocr 1990, 4, 409-416.
23. 23. Zhang B, Roth RA, A region of the insulin receptor important for ligand binding (residues 450-601) is recognized by patients' autoimmune antibodies and inhibitory monoclonal antibodies. Proc Natl Acad Sci USA 1991, 88, 9858-9862.
24. 24. Schumacher R, Soos MA, Schlessinger J et al. Signaling competent receptor chimeras allow mapping of major insulin receptor binding domains determinants. J Biol Chem 1993, 268, 1087-1094.
25. 25. Kjeldsen T, Wiberg FC, Andersen AS. Chimeric receptors indicate that phenylalanine 39 is a major contributor to insulin specificity of the insulin receptor. J Biol Chem 1994, 269, 32942-32946.
26. 26. De Meyts P, Christoffersen CT, Urso B et al. Role of the time factor in signaling specificity: Application to mitogenic and metabolic signaling by the insulin and insulin-like growth factor-I receptor tyrosine kinases. Metabolism 1995, 44, 2-11.
27. 27. De Meyts P, Bianco AR, Roth J. Site-site interactions among insulin receptors: Characterization of the negative cooperativity. J Biol Chem 1976, 251, 1877-1888.
28. 28. Rechler MM. Insulin-like growth factor binding proteins. Vitam Horm 1993, 47, 1-114.
29. 29. Baxter RC, Martin JL. Binding proteins for the insulin-like growth factors: Structure, regulation, and function. Progr Growth Factor Res 1989, 1, 49-68.
30. 30. De Meyts P. The structural basis of insulin and insulin-like growth factor-I (IGF-I) receptor binding and negative cooperativity, and its relevance to mitogenic versus metabolic signaling. Diabetologia 1994, 37, S135-S138.
31. 31. Traverse S, Gomez N, Paterson H et al. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem J 1992, 288, 351-355.
32. 32. Nguyen TT, Scimeca JC, Filloux C et al. Co-regulation of the mitogen-activated protein kinase, extracellular signal-regulated kinase 1, and the 90 kDa ribsomal S6 kinase in PC12 cells. Distinct effects of the neurotrophic factor, nerve growth factor, and the mitogenic factor, epidermal growth factor. J Biol Chem 1993, 268, 9803-9810.
33. 33. Zapf A, Hsu D, Olefsky JM. Comparison of the intracellular itineraries of insulin-like growth factor-I and insulin and their receptors in Rat-1 fibroblasts. Endocrinology 1994, 134, 2445-2452.
34. 34. Condorelli G, Smith RJ. Two alternatively spliced forms of the IGF-I receptor have distinct biological activities and hormone-induced internalization rates. Exp Clin Endocr 1993, 101, 95-97.
35. 35. Condorelli G, Bueno R, Smith R. Two alternatively spliced forms of the human insulin-like growth factor I receptor have distinct biological activities and internalization kinetics. J Biol Chem, 1994, 269, 8510-8516.
36. 36. Adamo M, Roberts Jr CT, Le Roith D. How distinct are the insulin and insulin-like growth factor I signalling systems? BioFactors 1992, 3, 151-157.
37. 37. Takata Y, Webster NJG, Olefsky JM. Mutation of the two carboxyl-terminal tyrosines results in an insulin receptor with normal metabolic signalling by enhanced mitogenic signalling properties. J Biol Chem 1991, 266, 9135-9139.
38. 38. Baron V, Gautier N, Kaliman P, Dolais-Kitabgi D, Van Obberghen E. The carboxyl-terminal domain of the insulin receptor: Its potential role in growth promoting effects. Biochemistry 1991, 30, 9365-9370.
39. 39. Lammers R, Gray A, Schlessinger J, Ullrich A. Differential signaling potential of insulin and IGF-I receptor cytoplasmic domains. EMBO J 1989, 8, 1369-1375.
40. 40. Kaleko M, Rutter WJ, Miller AD. Overexpression of the human insulin-like growth factor I receptor promotes ligand-dependent neoplastic transformation. Molec Cell Biol 1990, 10, 464-473.
41. 41. Blakesley VA, Kalebic T, Helman LJ et al. Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251 and 1316 in the carboxyl-terminus of the IGF-I receptor. Endocrinology 1995, 137, 410-417.
42. 42. Baserga R, Sell C, Porcu P, Rubini M. The role of the IGF-I receptor in growth and transformation of mammalian cells. Cell Proliferation 1994, 27, 63-71.
43. 43. Sell C, Rubini M, Rubin R, Liu J-P, Efstratiadis A, Baserga R. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type-I IGF receptor. Proc Natl Acad Sci USA 1993, 90, 11217-11221.
44. 44. Faria TN, Blakesley VA, Kato H, Stannard B, LeRoith D, Roberts Jr CT. Role of the carboxy-terminal domains of the insulin and insulin-like growth factor I receptors in receptor function. J Biol Chem 1994, 269, 13922-13928.
45. 45. McClain DA, Maegawa H, Levy J et al. Properties of a human insulin receptor with a COOH-terminal truncation. J Biol Chem 1988, 263, 8904-8911.
46. 46. Ando A, Momomura K, Tobe K et al. Enhanced insulin-induced mitogenesis and mitogen-activated protein kinase activities in mutant insulin receptors with substitution of two COOH-terminal tyrosine autophosphorylation sites by phenylalanine. J Biol Chem, 1992, 267, 12788-12792.
47. 47. Miura M, Surmacz E, Burgaud J-L, Baserga R. Different effects on mutagenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor. J Biol Chem 1995, 270, 22639-22644.
48. 48. Beitner-Johnson D, LeRoith D. Insulin-like growth factor-I stimulates tyrosine phosphorylation of endogenous c-Crk. J Biol Chem 1995, 270, 5187-5190.
49. 49. Beitner-Johnson D, Blakesley VA, Shen-Orr Z et al. The proto-oncogene product c-Crk associates with IRS-I and 4PS: modulation by IGF-I and enhanced IGF-I signaling. J Biol Chem 1996, 271, 9287-9290.
50. 50. Knight JB, Yamauchi K, Pessin JE. Divergent insulin and platelet-derived growth factor regulation of focal adhesion kinase tyrosine phosphorylation, and rearrangement of actin stress fibers. J Biol Chem 1995, 270, 10199-10203.
51. 51. Pillay TS, Sasaoka T, Olefsky JM. Insulin stimulates the tyrosine dephosphorylation of pp125 focal adhesion kinase. J Biol Chem 1995, 270, 991-994.
52. 52. Xu B, Bird VG, Miller WT. Substrate specificity of the insulin and insulin-like growth factor I receptor tyrosine kinase catalytic domains. J Biol Chem 1995, 270, 29825-29830.